Variant report
Variant | esv3332273 |
---|---|
Chromosome Location | chr2:234825310-234825891 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:62)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:234825101-234825354 | IMR90 | lung: | n/a | chr2:234825248-234825259 |
2 | CEBPB | chr2:234825137-234825381 | HepG2 | liver: | n/a | chr2:234825248-234825259 |
3 | CEBPB | chr2:234825172-234825336 | A549 | lung: | n/a | chr2:234825248-234825259 |
4 | CTCF | chr2:234825409-234825440 | IMR90 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:234825859-234825909 | ovcar-3 | ovarian: | n/a |
2 | chr2:234825859-234825909 | ovcar-3 | ovarian: | n/a |
3 | chr2:234825859-234825909 | SAEC | small airway: | n/a |
4 | chr2:234825859-234825909 | ECC-1 | luminal epithelium: | n/a |
5 | chr2:234825859-234825909 | IMR90 | lung: | fetal |
6 | chr2:234825859-234825909 | HCF | heart: | n/a |
7 | chr2:234825859-234825909 | Jurkat | blood: | n/a |
8 | chr2:234825859-234825909 | HRCEpiC | kidney: | n/a |
9 | chr2:234825859-234825909 | H1-hESC | embryonic stem cell: | embryo |
10 | chr2:234825859-234825909 | GM12878 | blood: | n/a |
11 | chr2:234825859-234825909 | SKMC | muscle: | n/a |
12 | chr2:234825859-234825909 | GM12891 | blood: | n/a |
13 | chr2:234825859-234825909 | Hepatocyte | liver: | n/a |
14 | chr2:234825859-234825909 | HEK293 | kidney: | embryo |
15 | chr2:234825859-234825909 | HRE | kidney: | n/a |
16 | chr2:234825859-234825909 | AG10803 | skin: | n/a |
17 | chr2:234825859-234825909 | HL-60 | blood: | n/a |
18 | chr2:234825859-234825909 | PANC-1 | pancreas: | n/a |
19 | chr2:234825859-234825909 | ProgFib | skin: | n/a |
20 | chr2:234825859-234825909 | SK-N-SH_RA | brain: | n/a |
21 | chr2:234825859-234825909 | NHDF-neo | bronchial: | n/a |
22 | chr2:234825859-234825909 | GM06990 | blood: | n/a |
23 | chr2:234825859-234825909 | HMEC | breast: | n/a |
24 | chr2:234825859-234825909 | HIPEpiC | eye: | n/a |
25 | chr2:234825859-234825909 | LNCaP | prostate: | n/a |
26 | chr2:234825859-234825909 | NT2-D1 | testis: | n/a |
27 | chr2:234825859-234825909 | HCT-116 | colon: | n/a |
28 | chr2:234825859-234825909 | BJ | skin: | n/a |
29 | chr2:234825859-234825909 | HAEpiC | amniotic membrane: | n/a |
30 | chr2:234825859-234825909 | HRPEpiC | eye: | n/a |
31 | chr2:234825859-234825909 | NB4 | blood: | n/a |
32 | chr2:234825859-234825909 | Hela-S3 | cervix: | n/a |
33 | chr2:234825859-234825909 | AG04449 | skin: | fetal |
34 | chr2:234825859-234825909 | Caco-2 | colon: | n/a |
35 | chr2:234825859-234825909 | AG09319 | gingival: | n/a |
36 | chr2:234825859-234825909 | NH-A | brain: | n/a |
37 | chr2:234825859-234825909 | HepG2 | liver: | n/a |
38 | chr2:234825859-234825909 | HEEpiC | esophagus: | n/a |
39 | chr2:234825859-234825909 | HNPCEpiC | eye: | n/a |
40 | chr2:234825859-234825909 | MCF-7 | breast: | n/a |
41 | chr2:234825859-234825909 | K562 | blood: | n/a |
42 | chr2:234825859-234825909 | A549 | lung: | n/a |
43 | chr2:234825859-234825909 | CMK | blood: | n/a |
44 | chr2:234825859-234825909 | SK-N-SH | brain: | n/a |
45 | chr2:234825859-234825909 | HUVEC | blood vessel: | n/a |
46 | chr2:234825859-234825909 | T-47D | breast: | n/a |
47 | chr2:234825859-234825909 | HPAEpiC | pulmonary alveolar: | n/a |
48 | chr2:234825859-234825909 | PFSK-1 | brain: | n/a |
49 | chr2:234825859-234825909 | NHBE | bronchial: | n/a |
50 | chr2:234825859-234825909 | HCM | heart: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:234761504..234764477-chr2:234824983..234827662,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TRPM8 | TF binding region |
TRPM8 | CpG island |
ENSG00000123485 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79251556 | chr2:234825349-234825350 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs2362290 | chr2:234825369-234825370 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs552710636 | chr2:234825391-234825392 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs573174686 | chr2:234825396-234825397 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs28901599 | chr2:234825406-234825407 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs572770153 | chr2:234825454-234825455 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs544805566 | chr2:234825473-234825474 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs575819665 | chr2:234825482-234825483 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs543609196 | chr2:234825546-234825547 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs9789675 | chr2:234825559-234825560 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs34870473 | chr2:234825585-234825586 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs529132258 | chr2:234825591-234825592 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs9789398 | chr2:234825624-234825625 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs544029858 | chr2:234825654-234825655 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs9789366 | chr2:234825662-234825663 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs529572445 | chr2:234825688-234825689 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs551090146 | chr2:234825754-234825755 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs547665668 | chr2:234825783-234825784 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs536763302 | chr2:234825859-234825860 | Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs1003540 | chr2:234825884-234825885 | Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS | CpG islandChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs11690675 | chr2:234825891-234825892 | Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Wilms tumour | 21544195 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:234825000-234825600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr2:234825000-234826000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:234825000-234827200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:234825600-234825800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr2:234825600-234826000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr2:234825800-234826000 | Enhancers | Brain Germinal Matrix | brain |
7 | chr2:234825800-234826200 | Bivalent Enhancer | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr2:234825800-234826200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr2:234825800-234826200 | Flanking Active TSS | Cortex derived primary cultured neurospheres | brain |
10 | chr2:234825800-234826400 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
11 | chr2:234825800-234826600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr2:234825800-234826600 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |